Catalyst Wire Dossier Catalyst Wire Dossier

Donepezil hydrochloride orally disintegrating tablet

donepezil hydrochloride · Teva Pharmaceuticals USA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Donepezil hydrochloride orally disintegrating tablet, covering 2011-02-21 to 2011-02-21. Get the full timeline:

Most recent: Clinical Trial Update: 10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Non-Fasting Conditions [Phase 1]

See pricing